9mon MSN
Popular weight-loss drugs like Wegovy fail to lower obesity-related cancer risks, study finds
Researchers analysed 48 previously-conducted trials which examined the safety and efficacy of GLP-1 drugs on people with type ...
CHRISTMAS… it’s THE ultimate eating challenge. But for the millions of us reportedly on weight loss jabs, what misery awaits?
I am bullish on healthcare stocks, especially pharmaceuticals, due to conservative valuations. Check out the healthcare ...
The Indian judiciary did well not to let Novo Nordisk extend its exclusive right to sell semaglutide, marketed as Ozempic and ...
For more than two years it had the entirety of the market for weight-loss drugs to itself. By 2023 sales of Wegovy had ...
Even so, in an interview with The Economist, Mr Doustdar sounded confident that Novo can recover. His prescription is to push ...
Obesity is a big driver of healthcare spending in South Africa, yet most medical schemes still limit cover for effective ...
Zacks Investment Research on MSN
CHMP backs higher-dose Wegovy as Novo Nordisk seeks 2026 EU approval
Novo Nordisk NVO announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) ...
FEELING achy, feverish or wiped out? As ‘superflu’ surges across the country, it might be easy to assume you’ve caught the ...
Pharmacists are urging people using weight loss injections to be alert to signs of dehydration as flu cases rise, warning ...
While both drugs share the same active ingredient, their positioning, pricing, and regulatory pathways diverge sharply, ...
Flu cases are soaring across Ireland, with hospital admissions under serious pressure, as the HSE warns there’s still no peak ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results